Business Services Industry
Emiliem Expands Management Team With Industry Veterans Donna Romero and Diane Beuving
Business Wire, May 7, 2008
KALAMAZOO, Mich. -- Emiliem, Inc., a privately-held biopharmaceutical company focused on discovering and developing novel molecular targeted therapeutics announced today that it has filled two key R&D positions on its management team.
Donna Romero, Ph.D. joins Emiliem as VP, Chemical Sciences and Pharmaceutical Development with over 20 years of experience in leading and supervising medicinal chemistry and drug discovery project teams across disciplines and therapeutic areas at the Upjohn, Pharmacia, and Pfizer pharmaceutical companies. Most recently, she was Senior Director of Medicinal Chemistry at Pfizer St. Louis Laboratories in the cardiovascular and inflammation therapeutic areas. While at Pharmacia, she was a Director of Medicinal Chemistry in CNS and Infectious Diseases. She also led the Bacterial Genome Team pursuing novel strategies to exploit the bacterial genome for the discovery of antibacterial agents with novel mechanisms of action. While a scientist at The Upjohn Company, she invented Rescriptor[R], a non-nucleoside reverse transcriptase inhibitor currently marketed for the treatment of HIV.
- Most Popular Articles in Business
- Research and Markets : Tesco Plc - SWOT Framework Analysis
- Do Us a Flavor - Ben & Jerry's Issues a Call for Euphoric New Flavors
- eBay made easy: ready to start an eBay business? These 5 simple steps will ...
- Katrina's lawsuit surge: a legal battle to force insurers to pay for flood ...
- Wal-Mart's newest distribution center opened last month near the southwest ...
- More »
Diane Beuving, M.S. joins Emiliem as Director of Project Management with over 20 years experience in project management and leading exploratory and full development teams in the Upjohn, Pharmacia, and Pfizer pharmaceutical companies. During this time she contributed to the development and regulatory approval of 16 marketed products in a wide range of therapeutic areas. Additionally, she has several years experience in international regulatory affairs and business development. Most recently she was Director, Global Project Management for Pfizer Michigan Laboratories.
Dale E. Johnson, Pharm.D., Ph.D., President and CEO of Emiliem, Inc., said, "We are extremely fortunate to have attracted both Donna and Diane to our management team. Individuals of this caliber and with years of relevant R&D experience put us squarely on track to be successful as we move our programs into early development."
Safe Harbor
This document is intended to provide specific information regarding initiatives of Emiliem, Inc. It is not intended as a general advertisement nor an offer to sell or a solicitation of an offer to buy any securities or an interest in Emiliem, Inc. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
COPYRIGHT 2008 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning